Pathogens: Our Allies against Cancer?
作者信息
Buonaguro Luigi, Cerullo Vincenzo
机构信息
Innovative Immunological Models, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione Pascale"-IRCCS, Via Mariano Semmola, 52, 80131 Naples, Italy.
Drug Research Program ImmunoViroTherapy Lab (IVTLAb), Faculty of Pharmacy, University of Helsinki, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland; Translational Immunology Program (TRIMM), University of Helsinki, Helsinki, Finland; Department of Molecular Medicine and Medical Biotechnology, Naples University "Federico II," S. Pansini 5, Italy.
出版信息
Mol Ther. 2021 Jan 6;29(1):10-12. doi: 10.1016/j.ymthe.2020.12.005. Epub 2020 Dec 5.
Abstract
摘要
相似文献
1
Pathogens: Our Allies against Cancer?病原体：对抗癌症的盟友？
Mol Ther. 2021 Jan 6;29(1):10-12. doi: 10.1016/j.ymthe.2020.12.005. Epub 2020 Dec 5.
2
Selected Articles from This Issue.本期精选文章。
Clin Cancer Res. 2020 Jul 1;26(13):3071.
3
Special issue: Translating extracellular matrix: From cancer progression to therapeutics.特刊：细胞外基质的转化：从癌症进展到治疗
Semin Cancer Biol. 2020 May;62:iii-v. doi: 10.1016/j.semcancer.2019.10.014. Epub 2019 Oct 23.
4
European society for medical oncology virtual congress: Molecular analysis for precision oncology, October 9th - October 10th, 2020.欧洲医学肿瘤学会虚拟大会：精准肿瘤学的分子分析，2020年10月9日至10月10日。
EBioMedicine. 2021 Feb;64:103219. doi: 10.1016/j.ebiom.2021.103219. Epub 2021 Jan 28.
5
We need to bring R0 < 1 to treat cancer too.我们也需要将 R0 < 1 用于癌症治疗。
Genome Med. 2021 Jul 26;13(1):120. doi: 10.1186/s13073-021-00940-9.
6
Introduction to Mathematical Oncology.数学肿瘤学导论
JCO Clin Cancer Inform. 2019 Apr;3:1-4. doi: 10.1200/CCI.19.00010.
7
The dual face of NAMPT: Intracellular/extracellular protein and diagnostic/therapeutic target in cancer.烟酰胺磷酸核糖转移酶的双重作用：癌症中的细胞内/细胞外蛋白及诊断/治疗靶点
EBioMedicine. 2020 Dec;62:103109. doi: 10.1016/j.ebiom.2020.103109. Epub 2020 Nov 5.
8
Editorial: Immune Cell Lineage Reprogramming in Cancer.社论：癌症中的免疫细胞谱系重编程
Front Immunol. 2022 Jan 19;12:838464. doi: 10.3389/fimmu.2021.838464. eCollection 2021.
9
Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy.社论：肿瘤微环境中自然杀伤细胞与髓系细胞的相互作用：对癌症免疫治疗的意义
Front Immunol. 2021 Jul 1;12:718844. doi: 10.3389/fimmu.2021.718844. eCollection 2021.
10
Nerves in cancer.癌症中的神经。
Nat Rev Cancer. 2020 Mar;20(3):143-157. doi: 10.1038/s41568-019-0237-2. Epub 2020 Jan 23.
引用本文的文献
1
Cross-reactive CD8 T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs).肿瘤相关抗原（TAA）和同源微生物群衍生抗原（MoA）的交叉反应性 CD8 T 细胞反应。
J Exp Clin Cancer Res. 2024 Mar 20;43(1):87. doi: 10.1186/s13046-024-03004-z.
2
Peptide-based vaccine for cancer therapies.基于肽的癌症治疗疫苗。
Front Immunol. 2023 Aug 16;14:1210044. doi: 10.3389/fimmu.2023.1210044. eCollection 2023.
3
Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case.病毒介导的抗肿瘤免疫中的抗原分子模拟：以 HIV 为例。
J Transl Med. 2022 Oct 15;20(1):472. doi: 10.1186/s12967-022-03681-4.
4
γδ T Cells in the Tumor Microenvironment-Interactions With Other Immune Cells.γδ T 细胞在肿瘤微环境中的作用-与其他免疫细胞的相互作用。
Front Immunol. 2022 Jul 11;13:894315. doi: 10.3389/fimmu.2022.894315. eCollection 2022.
5
Molecular mimicry between tumor associated antigens and microbiota-derived epitopes.肿瘤相关抗原与微生物群衍生表位之间的分子模拟。
J Transl Med. 2022 Jul 14;20(1):316. doi: 10.1186/s12967-022-03512-6.
6
Novel Molecular Targets for Hepatocellular Carcinoma.肝细胞癌的新型分子靶点
Cancers (Basel). 2021 Dec 28;14(1):140. doi: 10.3390/cancers14010140.
7
Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides.TuA 衍生的异源嵌合肽诱导的长期记忆 T 细胞作为预防抗癌免疫。
J Transl Med. 2021 Dec 24;19(1):526. doi: 10.1186/s12967-021-03194-6.
8
Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs).鉴定和验证与肿瘤相关抗原（TAA）具有序列和结构同源性的病毒抗原。
J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2021-002694.
本文引用的文献
1
Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma.病毒分子模拟影响鼠类和人类黑色素瘤的抗肿瘤免疫反应。
Cancer Immunol Res. 2021 Aug;9(8):981-993. doi: 10.1158/2326-6066.CIR-20-0814. Epub 2021 Jun 8.
2
Selecting Target Antigens for Cancer Vaccine Development.为癌症疫苗研发选择靶抗原
Vaccines (Basel). 2020 Oct 17;8(4):615. doi: 10.3390/vaccines8040615.
3
Commensal bacteria stimulate antitumor responses via T cell cross-reactivity.共生菌通过 T 细胞交叉反应刺激抗肿瘤反应。
JCI Insight. 2020 Apr 23;5(8):135597. doi: 10.1172/jci.insight.135597.
4
Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy.病毒特异性记忆 T 细胞浸润肿瘤组织，并可被重新用于肿瘤免疫治疗。
Nat Commun. 2019 Feb 4;10(1):567. doi: 10.1038/s41467-019-08534-1.
5
Unique true predicted neoantigens (TPNAs) correlates with anti-tumor immune control in HCC patients.独特的真实预测新抗原（TPNAs）与 HCC 患者的抗肿瘤免疫控制相关。
J Transl Med. 2018 Oct 19;16(1):286. doi: 10.1186/s12967-018-1662-9.
6
Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide.HLA-I 限制性扩展肿瘤相关肽的不同 T 细胞受体识别模式。
Nat Commun. 2018 Mar 12;9(1):1026. doi: 10.1038/s41467-018-03321-w.
7
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.胰腺癌长期存活者中独特新抗原特性的鉴定
Nature. 2017 Nov 23;551(7681):512-516. doi: 10.1038/nature24462. Epub 2017 Nov 8.
8
Interpreting T-Cell Cross-reactivity through Structure: Implications for TCR-Based Cancer Immunotherapy.通过结构解读T细胞交叉反应性：对基于T细胞受体的癌症免疫疗法的启示
Front Immunol. 2017 Oct 4;8:1210. doi: 10.3389/fimmu.2017.01210. eCollection 2017.
9
Broad TCR repertoire and diverse structural solutions for recognition of an immunodominant CD8 T cell epitope.广泛的TCR库以及识别免疫显性CD8 T细胞表位的多种结构解决方案。
Nat Struct Mol Biol. 2017 Apr;24(4):395-406. doi: 10.1038/nsmb.3383. Epub 2017 Feb 27.
10
Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.癌症免疫学。突变图谱决定非小细胞肺癌对程序性死亡受体1（PD-1）阻断治疗的敏感性。
Science. 2015 Apr 3;348(6230):124-8. doi: 10.1126/science.aaa1348. Epub 2015 Mar 12.
Zotero 插件